No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NKTX240816C2500
- 4.31
- 0.000.00%
15min DelayTrading May 16 13:13 ET
0.00High0.00Low
0.00Open4.31Pre Close0 Volume5 Open Interest2.50Strike Price0.00Turnover442.38%IV5.09%PremiumAug 16, 2024Expiry Date3.98Intrinsic Value100Multiplier25DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type0.9201Delta0.0196Gamma1.42Leverage Ratio-0.0226Theta0.0010Rho1.31Eff Leverage0.0025Vega
Intraday
- 5D
- Daily
News
Sector Update: Health Care Stocks Gain in Afternoon Trading
Health care stocks rose Tuesday afternoon with the NYSE Health Care Index gaining 0.9% and the Health Care Select Sector SPDR Fund (XLV) up 1.1%.The iShares Biotechnology ETF (IBB) climbed 1.7%.In
Nkarta Shares Rise After Co. Names President and Chief Medical Officer
By Stephen Nakrosis Shares of Nkarta were trading in the green Tuesday, after the biopharmaceutical company said a former executive will be returning in the newly-created role of president. The
Express News | Nkarta Shares Are Trading Higher After the Company Appointed Nadir Mahmood as President
Express News | Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
Nkarta (NKTX) Upgraded to Buy: Here's What You Should Know
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Nkarta (NASDAQ:NKTX) has seen its share price rise 141% over the last year, delighting many sh
Comments
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
7
$Nkarta(NKTX.US$ jesus have some mercy
$Nkarta(NKTX.US$ Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M
1
Read more